Equities

Imricor Medical Systems Inc

IMR:ASX

Imricor Medical Systems Inc

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.825
  • Today's Change0.015 / 1.85%
  • Shares traded117.10k
  • 1 Year change+41.99%
  • Beta0.8508
Data delayed at least 20 minutes, as of Nov 18 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments0.835.6919
Total Receivables, Net0.390.130.09
Total Inventory1.682.282.58
Prepaid expenses1.031.591.51
Other current assets, total------
Total current assets3.949.6823
Property, plant & equipment, net3.173.563.60
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term0.190.230.20
Other long term assets1.020.230.36
Total assets8.311427
LIABILITIES
Accounts payable2.100.260.69
Accrued expenses1.031.121.54
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.850.670.33
Other current liabilities, total0.580.020.18
Total current liabilities4.572.072.74
Total long term debt8.492.250.23
Total debt9.342.920.56
Deferred income tax------
Minority interest------
Other liabilities, total4.011.871.50
Total liabilities176.194.46
SHAREHOLDERS EQUITY
Common stock0.020.020.01
Additional paid-in capital1049795
Retained earnings (accumulated deficit)(113)(90)(73)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(8.75)7.5122
Total liabilities & shareholders' equity8.311427
Total common shares outstanding169151143
Treasury shares - common primary issue------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.